Cingulate Inc. - 8-K Filing

Cingulate Inc. targets December 2026 to January 2027 for CTx-1301 NDA resubmission following FDA Complete Response Letter. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

3 articles from 1 source · updated November 10, 2026, 21:12 UTC

Coverage

• AAON, INC. - 8-K Filing SEC EDGAR · November 10, 2026, 21:11 UTC
• Worksport Ltd - 8-K Filing SEC EDGAR · November 10, 2026, 21:03 UTC
• Cingulate Inc. - 8-K Filing SEC EDGAR · November 10, 2026, 13:10 UTC